source
- FDA’s top gene-therapy regulator Vijay Kumar steps down amid leadership shake-upVijay Kumar, the acting director of the FDA office that reviews cell and gene therapies, has announced he will leave his position. In an email to staff, Kumar said he reflected on his tenure and de…
- NEJM retracts pivotal data for Amgen's TavneosPivotal data for Amgen’s Tavneos have been retracted from the New England Journal of Medicine, creating another obstacle for the beleaguered autoimmune drug. Two academic authors requested the retr…Endpoints · 1mo ago↗ source